160 related articles for article (PubMed ID: 31958178)
1. Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients-a SCHEDULE trial substudy.
Nelson LM; Andreassen AK; Arora S; Andersson B; Gude E; Eiskjaer H; Rådegran G; Dellgren G; Gullestad L; Gustafsson F
Transpl Int; 2020 May; 33(5):517-528. PubMed ID: 31958178
[TBL] [Abstract][Full Text] [Related]
2. Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.
Arora S; Andreassen AK; Karason K; Gustafsson F; Eiskjær H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Dellgren G; Ueland T; Aukrust P; Gullestad L;
Circ Heart Fail; 2018 Sep; 11(9):e004050. PubMed ID: 30354362
[TBL] [Abstract][Full Text] [Related]
3. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F
Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
[TBL] [Abstract][Full Text] [Related]
4. Effect of everolimus initiation and early calcineurin inhibitor withdrawal on myocardial FOXP3+ regulatory T cells in heart transplantation.
Mirza K; Gustafsson F; Gullestad L; Arora S; Andersen C
Transpl Immunol; 2016 Sep; 38():75-7. PubMed ID: 27260644
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
[TBL] [Abstract][Full Text] [Related]
6. Intravascular ultrasound for cardiac allograft vasculopathy detection.
Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
[TBL] [Abstract][Full Text] [Related]
7. Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis.
Watanabe T; Seguchi O; Yanase M; Fujita T; Murata Y; Sato T; Sunami H; Nakajima S; Kataoka Y; Nishimura K; Hisamatsu E; Kuroda K; Okada N; Hori Y; Wada K; Hata H; Ishibashi-Ueda H; Miyamoto Y; Fukushima N; Kobayashi J; Nakatani T
Transplantation; 2017 Jun; 101(6):1310-1319. PubMed ID: 27472091
[TBL] [Abstract][Full Text] [Related]
8. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
[TBL] [Abstract][Full Text] [Related]
9. Risk Stratification for Cardiac Allograft Vasculopathy in Heart Transplant Recipients - Annual Intravascular Ultrasound Evaluation.
Sato T; Seguchi O; Ishibashi-Ueda H; Yanase M; Okada N; Kuroda K; Hisamatsu E; Sunami H; Watanabe T; Nakajima S; Wada K; Hata H; Fujita T; Fukushima N; Kobayashi J; Nakatani T
Circ J; 2016; 80(2):395-403. PubMed ID: 26701183
[TBL] [Abstract][Full Text] [Related]
10. Quantitative myocardial contrast echocardiography: a new method for the non-invasive detection of chronic heart transplant rejection.
Rutz T; de Marchi SF; Roelli P; Gloekler S; Traupe T; Steck H; Eshtehardi P; Cook S; Vogel R; Mohacsi P; Seiler C
Eur Heart J Cardiovasc Imaging; 2013 Dec; 14(12):1187-94. PubMed ID: 23612502
[TBL] [Abstract][Full Text] [Related]
11. Acute cellular rejection and the subsequent development of allograft vasculopathy after cardiac transplantation.
Raichlin E; Edwards BS; Kremers WK; Clavell AL; Rodeheffer RJ; Frantz RP; Pereira NL; Daly RC; McGregor CG; Lerman A; Kushwaha SS
J Heart Lung Transplant; 2009 Apr; 28(4):320-7. PubMed ID: 19332257
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One-Year Results of a Scandinavian Randomized Trial.
Arora S; Andreassen AK; Andersson B; Gustafsson F; Eiskjaer H; Bøtker HE; Rådegran G; Gude E; Ioanes D; Solbu D; Sigurdardottir V; Dellgren G; Erikstad I; Solberg OG; Ueland T; Aukrust P; Gullestad L;
Am J Transplant; 2015 Jul; 15(7):1967-75. PubMed ID: 25783974
[TBL] [Abstract][Full Text] [Related]
13. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
[TBL] [Abstract][Full Text] [Related]
14. Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study.
Chih S; Chong AY; Džavík V; So DY; Aleksova N; Wells GA; Bernick J; Overgaard CB; Stadnick E; Mielniczuk LM; Beanlands RSB; Ross HJ
Circ Heart Fail; 2023 Jun; 16(6):e010173. PubMed ID: 37165901
[TBL] [Abstract][Full Text] [Related]
15. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound.
Moayedi Y; Fan CPS; Tremblay-Gravel M; Miller RJH; Kawana M; Henricksen E; Parizo J; Wainwright R; Fearon WF; Ross HJ; Khush KK; Teuteberg JJ
Clin Transplant; 2020 Nov; 34(11):e14098. PubMed ID: 32970884
[TBL] [Abstract][Full Text] [Related]
17. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.
Kobashigawa JA; Pauly DF; Starling RC; Eisen H; Ross H; Wang SS; Cantin B; Hill JA; Lopez P; Dong G; Nicholls SJ;
JACC Heart Fail; 2013 Oct; 1(5):389-99. PubMed ID: 24621971
[TBL] [Abstract][Full Text] [Related]
18. Effect of everolimus introduction on cardiac allograft vasculopathy--results of a randomized, multicenter trial.
Arora S; Ueland T; Wennerblom B; Sigurdadottir V; Eiskjær H; Bøtker HE; Ekmehag B; Jansson K; Mortensen SA; Saunamaki K; Simonsen S; Gude E; Bendz B; Solbu D; Aukrust P; Gullestad L
Transplantation; 2011 Jul; 92(2):235-43. PubMed ID: 21677600
[TBL] [Abstract][Full Text] [Related]
19. Combined heart and kidney transplantation-Is there a protective effect against cardiac allograft vasculopathy using intravascular ultrasound?
Sato T; Cheng R; Azarbal B; Kittleson M; Patel J; Czer L; Levine R; Dimbil S; Olymbios M; Anzai T; Kransdorf E; Chang DH; Hamilton MA; Esmailian F; Kobashigawa J
J Heart Lung Transplant; 2019 Sep; 38(9):956-962. PubMed ID: 31301966
[TBL] [Abstract][Full Text] [Related]
20. Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.
Gustafsson F; Andreassen AK; Andersson B; Eiskjær H; Rådegran G; Gude E; Jansson K; Solbu D; Karason K; Arora S; Dellgren G; Gullestad L;
Transplantation; 2020 Jan; 104(1):154-164. PubMed ID: 30893292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
